SCHEMBL19302294

SCHEMBL19302294

CCC(CC)NCCOc1cnc2[nH]cc(Cc3ccc(NCc4ccc(Cl)cc4)nc3)c2c1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CSF1R P07333 3/20 0.56
▸ CYP3A4 P08684 11/20 0.55
▸ CYP2C19 P33261 5/20 0.55
▸ CYP1A2 P05177 2/20 0.55
▸ CYP2D6 P10635 1/20 0.54
▸ KIT P10721 2/20 0.51
▸ LCK P06239 1/20 0.51
▸ PGR P06401 1/20 0.51
▸ CHRM2 P08172 1/20 0.51
▸ HTR1A P08908 1/20 0.51
▸ ADRA2A P08913 1/20 0.51
▸ PDGFRB P09619 1/20 0.51
▸ ADORA3 P0DMS8 1/20 0.51
▸ CHRM1 P11229 1/20 0.51
▸ PDGFRA P16234 1/20 0.51
▸ FLT1 P17948 1/20 0.51
▸ DRD1 P21728 1/20 0.51
▸ TBXA2R P21731 1/20 0.51
▸ SLC6A2 P23975 1/20 0.51
▸ ADORA1 P30542 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19302388 0.89 CSF1R (0.73) CSF1RCYP3A4CYP2C19CYP1A2CYP2D6
SCHEMBL1267219 0.84 CSF1R (0.57) CSF1RCYP3A4CYP2C19CYP1A2CYP2D6
SCHEMBL1267844 0.84 CSF1R (0.77) CSF1RCYP3A4CYP2C19CYP1A2CYP2D6
SCHEMBL1267958 0.79 CYP3A4 (0.83) CSF1RCYP3A4CYP2C19CYP1A2CYP2D6
SCHEMBL1267483 0.78 CYP3A4 (0.54) CSF1RCYP3A4CYP2C19CYP1A2CYP2D6
SCHEMBL857477 0.77 CYP3A4 (0.69) CSF1RCYP3A4CYP2C19CYP1A2CYP2D6
SCHEMBL2181556 0.77 CYP3A4 (0.69) CSF1RCYP3A4CYP2C19CYP1A2CYP2D6
SCHEMBL14620861 0.77 CYP3A4 (0.69) CSF1RCYP3A4CYP2C19CYP1A2CYP2D6
SCHEMBL21304793 0.77 CSF1R (0.59) CSF1RCYP3A4CYP2C19CYP1A2CYP2D6
SCHEMBL19302326 0.76 CSF1R (0.58) CSF1RCYP3A4CYP2C19CYP1A2CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170247370-A1 COMPOUNDS MODULATING C-FMS AND/OR C-KIT ACTIVITY AND USES THEREFOR PLEXXIKON INC. 2017-08-31 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170247370-A1 COMPOUNDS MODULATING C-FMS AND/OR C-KIT ACTIVITY AND USES THEREFOR KIT, FLT3, FLT1 CSF1R 4/4885CYP3A4 3847/4885CYP2C19 3327/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback